Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
- 1 December 1999
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 35 (13), 1773-1782
- https://doi.org/10.1016/s0959-8049(99)00229-4
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucoseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy?European Journal Of Cancer, 1995
- Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroidsJournal of Neurosurgery, 1995
- Acute effect of carmustine on glucose metabolism in brain and glioblastomaCancer, 1994
- Correlation of glucose consumption and tumor cell density in astrocytomasJournal of Neurosurgery, 1993
- In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatmentCancer, 1993
- Early effects of intra-arterial chemotherapy in patients with brain tumours studied with PETNuclear Medicine Communications, 1989
- Changes of Cerebral Blood Flow, and Oxygen and Glucose Metabolism Following Radiochemotherapy of GliomasJournal of Computer Assisted Tomography, 1988
- The Influence of Tissue Heterogeneity on Results of Fitting Nonlinear Model Equations to Regional Tracer Uptake Curves: With an Application to Compartmental Models Used in Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1987
- Measurement of Glucose Utilisation with [18F]2-Fluoro-2-Deoxy-D-Glucose: A Comparison of Different Analytical MethodsJournal of Cerebral Blood Flow & Metabolism, 1987